SETH PERMANN: Open Payments
NPI 1508855974 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,478 in 70 payments from 14 companies in 2025. Trend: 2023 $1,349 · 2024 $2,900 · 2025 $2,478
Food & beverage: $1,503Consulting: $800Education: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $1,355 |
| Janssen Biotech, Inc. | 11 | $240 |
| UCB, Inc. | 10 | $203 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $107 |
| Galderma Laboratories, L.P. | 4 | $98 |
| LEO Pharma Inc. | 2 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $95 |
| Organon LLC | 7 | $83 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| Amgen Inc. | 2 | $38 |
Products named: RINVOQ, SKYRIZI, TREMFYA, Bimzelx, ANZUPGO, DUPIXENT, NEMLUVIO, Sotyktu.
Industry payments across ID — which companies pay providers there.
